ORIGINAL RESEARCH
Accepted on 27 May 2025
PD-1 Inhibitor-Augmented HAIC-TKI Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Real-World Survival Benefits, Safety, and Subgroup-Specific Efficacy
doi 10.3389/fimmu.2025.1602031
- 113 views